Head and neck involvement of Kaposi’s sarcoma is rarely encountered, especially for the Mediterranean classic subtype. Here we report a case of non-AIDS related laryngeal Kaposi’s sarcoma in a 77-year-old Tunisian man complaining of 4-month history of hoarseness and dysphagia. The patient underwent exclusive local radiotherapy with a prescription dose of 45 Gy delivered in 1.8 Gy daily fractions. He remained complaint-free for 3 months.
Medulloblastoma is the most common malignant brain tumor in children. This entity in adulthood is rare. The aim of our study is to evaluate therapeutic results and prognostic factors of adult medul...
11 September 2026 in Journal of Radiotherapy in Practice
Purpose: Radiation-induced primary hypothyroidism is a common yet under-recognized toxicity after radiotherapy for undifferentiated nasopharyngeal carcinoma (UNPC). This study evaluated clinical and dosimetric predictors of hypothyroidism following intensity modulated radiotherapy (IMRT). Methods: We retrospectively analyzed 50 non-metastatic (M0) UNPC patients treated with IMRT at the Salah Azaiez Institute (2016–2019), with regular thyroid function follow-up (12–60 months). Dosimetric parameters were reviewed for associations with thyroid dysfunction. Results: Hypothyroidism developed in 66% of patients (median onset: 26 months). Its risk was increased with a mean thyroid dose ≥56.67 Gy. Sparing less than 9.9 cc of thyroid tissue from 60 Gy (VS60) strongly predicted hypothyroidism (AUC 0.952, 95% CI 0.886–1; sensitivity 93.9%; specificity 100%). Affected patients had smaller thyroid glands (14.73 ± 6.14 vs. 19.17 ± 7.07cc; p = 0.026) and higher mean thyroid doses (59.8 ± 4.27 vs. 55.19 ± 3.41Gy; p < 0.001). Female sex ( p = 0.035), higher T stage ( p = 0.007), and nodal involvement ≥N2 ( p = 0.003) were also significant predictors. Conclusions: Radiation-induced hypothyroidism is a frequent, dose-dependent toxicity in UNPC. Preserving ≥9.9 cc of thyroid tissue below 60 Gy may reduce risk. Prospective validation is needed to confirm reliable dose thresholds.